Vimarsana
Biggest News Aggregation in the World

Page 8 - Immunic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Today - Breaking & Trending Today

Immunic, Inc. (NASDAQ:IMUX) Sees Significant Decrease in Short Interest - Vimarsana News

Immunic, Inc. (NASDAQ:IMUX) Sees Significant Decrease in Short Interest

Immunic, Inc. (NASDAQ:IMUX – Get Rating) was the recipient of a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 3,650,000 shares, a decrease of 14.7% from the April 15th total of 4,280,000 shares. Based on an average trading volume of 1,310,000 shares, the short-interest […]

Source: wkrb13.com
Immunic, Inc. (NASDAQ:IMUX) Short Interest Update - Vimarsana News

Immunic, Inc. (NASDAQ:IMUX) Short Interest Update

Immunic, Inc. (NASDAQ:IMUX – Get Rating) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totalling 3,650,000 shares, a decline of 14.7% from the April 15th total of 4,280,000 shares. Based on an average trading volume of 1,310,000 shares, the days-to-cover ratio is presently […]

Immunic Inc set to bring relief with encouraging results - Vimarsana News

Immunic Inc set to bring relief with encouraging results

<iframe src=https://www.youtube.com/embed/-1tdPdVJr_M></iframe>Dr Daniel Vitt, CEO of Immunic Inc , discusses the company's encouraging first-quarter performance with Proactive.The... | May 16, 2023

Head to Head Contrast: ObsEva (NASDAQ:OBSV) and Immunic (NASDAQ:IMUX) - Vimarsana News

Head to Head Contrast: ObsEva (NASDAQ:OBSV) and Immunic (NASDAQ:IMUX)

Immunic (NASDAQ:IMUX – Get Rating) and ObsEva (NASDAQ:OBSV – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, risk, dividends and valuation. Institutional and Insider Ownership 60.7% of Immunic shares are held by […]

Immunic: Q1 Earnings Snapshot | MarketScreener - Vimarsana News

Immunic: Q1 Earnings Snapshot | MarketScreener

NEW YORK — NEW YORK — Immunic, Inc. on Thursday reported a loss of $25.3 million in its first quarter. On a per-share basis, the New York-based company said it had a loss of 58... | May 11, 2023